000 | 01427 a2200397 4500 | ||
---|---|---|---|
005 | 20250516224108.0 | ||
264 | 0 | _c20150710 | |
008 | 201507s 0 0 eng d | ||
022 | _a1365-2265 | ||
024 | 7 |
_a10.1111/cen.12566 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSanthanam, Prasanna | |
245 | 0 | 0 |
_aRole of (18) F-FDOPA PET/CT imaging in endocrinology. _h[electronic resource] |
260 |
_bClinical endocrinology _cDec 2014 |
||
300 |
_a789-98 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdrenal Gland Neoplasms _xdiagnostic imaging |
650 | 0 | 4 | _aCarbidopa |
650 | 0 | 4 |
_aCarcinoid Tumor _xdiagnostic imaging |
650 | 0 | 4 | _aCarcinoma, Neuroendocrine |
650 | 0 | 4 |
_aDihydroxyphenylalanine _xanalogs & derivatives |
650 | 0 | 4 | _aDopamine Agents |
650 | 0 | 4 | _aFluorodeoxyglucose F18 |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMultimodal Imaging |
650 | 0 | 4 |
_aNeuroendocrine Tumors _xdiagnostic imaging |
650 | 0 | 4 |
_aParaganglioma _xdiagnostic imaging |
650 | 0 | 4 |
_aPheochromocytoma _xdiagnostic imaging |
650 | 0 | 4 | _aPositron-Emission Tomography |
650 | 0 | 4 | _aRadiopharmaceuticals |
650 | 0 | 4 |
_aThyroid Neoplasms _xdiagnostic imaging |
650 | 0 | 4 | _aTomography, X-Ray Computed |
700 | 1 | _aTaïeb, David | |
773 | 0 |
_tClinical endocrinology _gvol. 81 _gno. 6 _gp. 789-98 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/cen.12566 _zAvailable from publisher's website |
999 |
_c24037952 _d24037952 |